[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596932":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":13,"centralContacts":22,"locations":32,"responsibleParty":55,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":10,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"National Institute of Allergy and Infectious Diseases (NIAID)","NIH",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Participants with atopic disease (asthma or atopic dermatitis)",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Age\u002Fsex-matched healthy volunteers.",[14,18],{"name":15,"affiliation":16,"role":17},"Ian Myles, MD","NIAID, National Institutes of Health (NIH)","PRINCIPAL_INVESTIGATOR",{"name":19,"affiliation":20,"role":21},"Kingsley Osei-Karikari","National Institutes of Health (NIH)","STUDY_CHAIR",[23,28],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Cisse Lamissa, MD","CONTACT","+223 66956944","lamissa05@gmail.com",{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},"Khadida Ouattara, MD, MSc","+223 66780357","zankhadi@gmail.com",[33,47],{"facility":34,"status":35,"city":36,"state":10,"zip":10,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Dermatology Hospital of Bamako","RECRUITING","Bamako","Mali","ML",{"type":40,"coordinates":41},"Point",[42,43],-7.97522,12.60915,{"lat":43,"lon":42},[46],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},{"facility":48,"status":35,"city":36,"state":10,"zip":10,"country":37,"countryCode":38,"cosmosGeoPoint":49,"geoPoint":51,"contacts":52},"Pneumology Ward, Point G University Hospital",{"type":40,"coordinates":50},[42,43],{"lat":43,"lon":42},[53],{"name":54,"role":25,"phone":30,"phoneExt":10,"email":31},"Khadida Ouattara, MD, M.Sc.",{"type":56,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100596932","microbiome-and-atopy-in-mali-100596932",false,"NCT07051902","Microbiome and Atopy in Mali","Analyzing the Microbiome and Environmental Exposures of Patients Suffering From Atopic Diseases in Mali","Inclusion Criteria (Study Group):\n\n* Aged ≥3 years.\n* Able to provide informed consent (for ages ≥18 years) or has a parent or guardian who can provide informed consent on their behalf (for ages \\\u003C18 years).\n* Positive Screening questionnaire for asthma or eczema.\n* Diagnosed with atopic dermatitis or asthma via physician diagnosis and criteria as follows:\n* Clinical diagnosis of atopic disease, as defined by Hanifin and Rajka criteria, that has been present for ≥3 months before the screening visit.\n\nInclusion Criteria (Healthy Volunteers):\n\n* Aged ≥3 years.\n* Able to provide informed consent (for ages ≥18 years) or has a parent or guardian who can provide informed consent on their behalf (for ages \\\u003C18 years).\n* Negative Screening questionnaire for asthma and eczema.\n* In good general health as evidenced by medical history and not diagnosed with atopic dermatitis or asthma via physician diagnosis.\n* Failure to meet Hanifin and Rajka criteria and \\\u003C3 on GINA guidelines for asthma diagnosis.\n* No self-reported history of food allergy.\n\nExclusion Criteria:\n\n* Use of antibiotics in the 3 months prior to screening.\n* Current pregnancy or lactation (determined by self-report).\n* Treatment with an investigational drug within 12 months prior to screening.\n* Current smoker or tobacco use within 4 months prior to screening.\n* Current skin infections other than atopic dermatitis (e.g., scabies).\n* Active diarrhea as defined by three or more loose stools per day (Bristol stool scale score of 6 or 7).\n* Presence of current bacterial, viral, or fungal infection, with the exception of isolated onchomycosis, which is not exclusionary.\n* Any other condition or factor that the investigator determines may significantly influence the results of testing.",true,"ALL","3 Years",{"count":68,"type":69},288,"ESTIMATED","OBSERVATIONAL","This study is about allergic diseases in people living in Mali. Allergic diseases can cause health problems like asthma or skin rashes. In this study, the investigators will look for clues about things that may affect whether people get allergic diseases. The investigators will look at things on or in the body, like germs, and things in the environment, like pollution. To do this, the investigators will collect different types of biological samples, health information, and environmental information from people with allergic diseases and people without allergic diseases. The investigators will compare what is found in each group to look for differences that might be related to allergic disease.",[73],"Atopic Disease",[75,76,77],"asthma","atopic dermatitis","allergies","2026-04-10",{"date":80,"type":81},"2026-04-15","ACTUAL",{"date":83,"type":81},"2025-09-30",{"date":85,"type":69},"2026-12",{"name":5,"class":6},2]